Patents by Inventor Philippe Bouissou

Philippe Bouissou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
    Patent number: 9457038
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: October 4, 2016
    Assignee: GALDERMA S.A.
    Inventors: Alexandre Kaoukhov, Christophe Villard, Philippe Bouissou
  • Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
    Patent number: 8987218
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: March 24, 2015
    Assignee: Galderma S.A.
    Inventors: Alexandre Kaoukhov, Christophe Villard, Philippe Bouissou
  • ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES
    Publication number: 20140256662
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 11, 2014
    Applicant: Galderma S.A.
    Inventors: Alexandre KAOUKHOV, Christophe VILLARD, Philippe BOUISSOU
  • Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies
    Patent number: 8361974
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: January 29, 2013
    Assignee: Galderma S.A.
    Inventors: Alexandre Kaoukhov, Christophe Villard, Philippe Bouissou
  • ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES
    Publication number: 20120053140
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Application
    Filed: June 14, 2011
    Publication date: March 1, 2012
    Applicant: Galderma S.A.
    Inventors: Alexandre KAOUKHOV, Christophe VILLARD, Philippe BOUISSOU
  • ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES
    Publication number: 20090093421
    Abstract: Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.
    Type: Application
    Filed: March 31, 2008
    Publication date: April 9, 2009
    Applicant: GALDERMA S.A.
    Inventors: Alexandre KAOUKHOV, Christophe VILLARD, Philippe BOUISSOU